AMA-0247

N/A

Report date: 2025/06/11 20:01:15
NME

Base Information

Drug NameAMA-0247
Drug Alias NameRho Associated Protein Kinase Inhibitors (Amakem)ROCK inhibitors (Amakem)AMA-237AMA-0831AMA-63 +[7] 
ClassificationSmall molecules
Mechanisms of ActionRho-associated kinases inhibitors
TargetsRho-associated kinases
Therapy Area/IndicationsFibrosisPulmonary Disease, Chronic ObstructiveAsthma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryBelgiumUnited Kingdom
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesAmakem Nv
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesHalo BioConsulting LtdAmakem Nv
Active IndicationsN/A
Inactive IndicationsFibrosisPulmonary Disease, Chronic ObstructiveAsthma

Other Information

ATC CodeN/A
Related LinksN/A